dissolution changes with a new Dilantin (phenytoin) formulation

Pfizer is notifying pharmacists about dissolution changes with a new Dilantin (phenytoin) formulation.

Dilantin 100 mg extended release capsules were reformulated with a new filler that affects dissolution.

This new formulation dissolves differently...and doesn't pass the standard dissolution test called "USP Test 1."

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote